Diffuse Intrinsic Pontine Glioma Clinical Trials in Ann Arbor, Michigan

4 studies are recruiting for diffuse intrinsic pontine glioma in Ann Arbor, Michigan right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Targeted Pediatric High-Grade Glioma Therapy

    The goal of this study is to perform genetic sequencing on brain tumors from children, adolescents, and young adult patients who have been newly diagnosed with a high-grade glioma. This molecular profiling will decide if patients are eligible to participate in a subsequent treatment-based clinical …

    Stage
    Not phased
    Ages
    1 to 39
    Site
    C.S. Mott Children's Hospital, Ann Arbor, Michigan
    Locations
    22 in total
    Run by
    Nationwide Children's Hospital

    See if you can join NCT05839379 on ClinicalTrials.gov

  2. PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

    This study will address the question of whether targeting CMV antigens with PEP-CMV can serve as a novel immunotherapeutic approach in pediatric patients with newly-diagnosed high-grade glioma (HGG) or diffuse intrinsic pontine glioma (DIPG) as well as recurrent medulloblastoma (MB). PEP-CMV is a v…

    Stage
    Phase 2
    Ages
    3 to 39
    Site
    C.S. Mott Children's Hospital, Ann Arbor, Michigan
    Locations
    13 in total
    Run by
    Nationwide Children's Hospital

    See if you can join NCT05096481 on ClinicalTrials.gov

  3. Combination Therapy for the Treatment of Diffuse Midline Gliomas

    This phase II trial determines if the combination of ONC201 with different drugs is effective for treating participants with diffuse midline gliomas (DMGs). Despite years of research, little to no progress has been made to improve outcomes for participants with DMGs, and there are few treatment opt…

    Stage
    Phase 2
    Ages
    2 to 39
    Site
    University of Michigan, Ann Arbor, Michigan
    Locations
    32 in total
    Run by
    University of California, San Francisco

    See if you can join NCT05009992 on ClinicalTrials.gov

  4. Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

    The goal of this study is to determine the efficacy of the 1) ribociclib and everolimus to treat pediatric and young adult patients newly diagnosed with a high-grade glioma (HGG), including DIPG, that have genetic changes in pathways (cell cycle, PI3K/mTOR) that these drugs target or 2) ribociclib …

    Stage
    Phase 2
    Ages
    1 to 39
    Site
    C.S. Mott Children's Hospital, Ann Arbor, Michigan
    Locations
    20 in total
    Run by
    Nationwide Children's Hospital

    See if you can join NCT05843253 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.